Tekla Life Sciences Investors $ 20.89 -0.11 (-0.52%)
Warning! GuruFocus has detected 2 Medium warning signs with HQL. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for HQL (Tekla Life Sciences Investors) from 1990 to Feb 27 2021. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Tekla Life Sciences Investors stock (HQL) PE ratio as of Feb 27 2021 is 4.07. More Details
Tekla Life Sciences Investors PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Tekla Life Sciences Investors PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Compare LSE:HHI MIL:CALT XSGO:NITRATOS XKRX:041190 LSE:JAI LSE:LAHL ASX:NGI LSE:ELTA ASX:PMC MIL:DEA LSE:JPE LSE:THRG LSE:OCI MIC:UCSS LSE:PSDL NAS:BKCC LSE:AAS XSWX:CPEN LSE:SLS XPAR:ABCA
Traded in other countries HQL.USA
Address 100 Federal Street, 19th Floor, Boston, MA, USA, 02110
Tekla Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in the securities of life sciences companies. The fund invests in the securities of public and private companies.